NOVARTIS AG DRN financial statements, including revenue, expenses, profit, and loss

The total revenue of N1VS34 for the last quarter is 70.60 B BRL, and it's 22.54% higher compared to the previous quarter. The net income of Q2 24 is 18.32 B BRL.